Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Sequencing of anthracyclines and taxanes in neoadjuvant and adjuvant therapy for early breast cancer

Esta versión no es la más reciente

ver la versión actual 18 febrero 2019

Información

DOI:
https://doi.org/10.1002/14651858.CD012873Copiar DOI
Base de datos:
  1. Cochrane Database of Systematic Reviews
Versión publicada:
  1. 21 noviembre 2017see what's new
Tipo:
  1. Intervention
Etapa:
  1. Protocol
Grupo Editorial Cochrane:

  1. Grupo Cochrane de Cáncer de mama

Copyright:
  1. Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Cifras del artículo

Altmetric:

Citado por:

Citado 0 veces por enlace Crossref Cited-by

Contraer

Autores

  • Milita Zaheed

    Correspondencia a: Medical Oncology Department, Concord Repatriation General Hospital, Concord, Australia

    [email protected]

  • Nicholas Wilcken

    Medical Oncology, Crown Princess Mary Cancer Centre, Westmead, Australia

    Sydney Medical School, The University of Sydney, Sydney, Australia

  • Melina L Willson

    Systematic Reviews and Health Technology Assessments, NHMRC Clinical Trials Centre, The University of Sydney, Sydney, Australia

  • Dianne L O'Connell

    Cancer Research Division, Cancer Council NSW, Sydney, Australia

  • Annabel Goodwin

    Medical Oncology Department, Concord Repatriation General Hospital, Concord, Australia

    Concord Clinical School, The University of Sydney, Concord Repatriation General Hospital, Concord, Australia

    Cancer Genetics Department, Sydney Local Health District and South Western Sydney Local Health District, Sydney, Australia

Contributions of authors

  1. Drafting the protocol: MZ and AG

  2. Study selection: MZ and AG

  3. Extracting data from studies: MZ and MW

  4. Entering data into RevMan: MZ

  5. Carrying out the analysis: MZ, MW and DO'C

  6. Interpreting the analysis: MZ, AG, MW, NW and DO'C

  7. Drafting the final review: MZ, AG, MW, NW and DO'C

  8. Disagreement resolution: AG, NW, MW, DO'C

  9. Updating the review: MZ

Sources of support

Internal sources

  • None, Other.

External sources

  • None, Other.

Declarations of interest

MZ: none known
MLW: none known
NW: none known
DO'C: none known
AG: none known

Acknowledgements

We would like to acknowledge the help received from Slavica Berber, Information Specialist at the Cochrane Breast Cancer Group, for developing the search strategies.

Version history

Published

Title

Stage

Authors

Version

2019 Feb 18

Sequencing of anthracyclines and taxanes in neoadjuvant and adjuvant therapy for early breast cancer

Review

Milita Zaheed, Nicholas Wilcken, Melina L Willson, Dianne L O'Connell, Annabel Goodwin

https://doi.org/10.1002/14651858.CD012873.pub2

2017 Nov 21

Sequencing of anthracyclines and taxanes in neoadjuvant and adjuvant therapy for early breast cancer

Protocol

Milita Zaheed, Nicholas Wilcken, Melina L Willson, Dianne L O'Connell, Annabel Goodwin

https://doi.org/10.1002/14651858.CD012873

Keywords

MeSH

Medical Subject Headings (MeSH) Keywords

Medical Subject Headings Check Words

Female; Humans;

PICO

Population
Intervention
Comparison
Outcome

El uso y la enseñanza del modelo PICO están muy extendidos en el ámbito de la atención sanitaria basada en la evidencia para formular preguntas y estrategias de búsqueda y para caracterizar estudios o metanálisis clínicos. PICO son las siglas en inglés de cuatro posibles componentes de una pregunta de investigación: paciente, población o problema; intervención; comparación; desenlace (outcome).

Para saber más sobre el uso del modelo PICO, puede consultar el Manual Cochrane.